Evidence map›Paper›PMID 40338107›Full record

ArticleHIV medicine2025

HIV molecular network in Mexico City (2021-2022): Understanding transmission dynamics through the role of newly diagnosed cases.

Samuel E Schulz-Medina, Daniela Tapia-Trejo, Margarita Matías-Florentino, Dulce M López-Sánchez, Claudia García-Morales, Jessica Monreal-Flores, Ángeles Beristain-Barreda, Miroslava Cárdenas-Sandoval, Manuel Becerril-Rodríguez, Silvia Del Arenal-Sánchez and 8 more

Abstract read
In one paragraph

Article in HIV medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. HIV Transmission Dynamics in Greater Mexico City are Shaped by Dense Spatial Mixing.medRxiv : the preprint server for health sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Samuel E Schulz-MedinaCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.ORCID https://orcid.org/0009-0002-7818-4869
Daniela Tapia-TrejoCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Margarita Matías-FlorentinoCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Dulce M López-SánchezCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-7318-0618
Claudia García-MoralesCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Jessica Monreal-FloresCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Ángeles Beristain-BarredaCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Miroslava Cárdenas-SandovalCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Manuel Becerril-RodríguezCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Silvia Del Arenal-SánchezCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Verónica Quiroz-MoralesCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Steven WeaverInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Joel O WertheimDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Raúl Adrián Cruz-FloresMexico City Ministry of Health, Clínica Especializada Condesa, Mexico City, Mexico.
Gustavo Reyes-TeránCoordinating Commission of the National Institutes of Health and High Specialty Hospitals, Mexico City, Mexico.
Andrea González-RodríguezMexico City Ministry of Health, Clínica Especializada Condesa, Mexico City, Mexico.
Santiago Ávila-RíosCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Vanessa Dávila-ConnCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
CIHR PJT-148621CIHR PJT-159625Consejo Nacional de Humanidades Ciencia y Tecnología 303079Mexican Government P016NIAID NIH HHS P30 AI036214San Diego Center for AIDS Research International Pilot Grant 112605914
6 · The paper itself

Abstract

objectiveWe aimed to infer and describe Mexico City's HIV genetic transmission network from 2021 through 2022 by characterizing its members based on time since HIV acquisition, as well as sociodemographic, clinical, and behavioural characteristics. Additionally, we assessed clustering potential according to time since HIV acquisition.

methodsIndividuals with a recent HIV diagnosis at the largest HIV clinic in Mexico City were invited to participate, completing self-administered questionnaires on sociodemographic, clinical, and behavioural characteristics. Blood samples were collected for analysis of the HIV pol gene using next-generation sequencing. The stage of infection at diagnosis was determined using an algorithm that includes antibody avidity tests. Genetic transmission network analysis used the Seguro HIV-TRACE tool.

resultsOf 6703 participants, 561 (8.4%) were identified as people newly living with HIV (PNLH). Transmission network analysis identified 896 clusters; 30.2% had at least one PNLH. Among all individuals, 43.5% formed clusters, with 11.8% being PNLH. PNLH added to a cluster showed higher odds for higher education, engaging in commercial sex, use of dating apps, annual HIV screening, and engaging in high-risk sexual practices (p < 0.05). Clusters with PNLH exhibited greater growth rates than those without PNLH (p < 0.05).

conclusionsThe presence of PNLH in clusters was associated with a higher growth rate. Tailored prevention strategies are crucial, including using dating apps for risk communication, promoting PrEP use, and safe sexual practices in sex venues, and enhancing harm reduction related to drug use. PNLH could be key candidates for interventions aimed at breaking transmission chains, including contact tracing.

Indexed as

HIV InfectionsAdolescentAdultFemaleHumansMaleMexicoMiddle Agedpol Gene Products, Human Immunodeficiency VirusSexual BehaviorSurveys and QuestionnairesYoung Adultpol Gene Products, Human Immunodeficiency Virusantibody affinitycluster analysisHIV‐1molecular epidemiologytransmission network

Identifiers

PMID40338107
PMCPMC12512910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.